Research News
View articles by month and year
21–26 of 26 articles
-
New Chemo Meds Improve Survival for Women with Advanced-Stage Disease
Newer chemotherapy medicines and regimens, as well as targeted therapy medicines, are helping women with advanced-stage breast cancer live longer.
-
Cancers Resistant to Anthracyclines May Respond to Taxotere-Xeloda Combo
A new study suggests that breast cancer that is resistant to an anthracycline may respond to a combination of two other chemotherapies, Taxotere (chemical name: docetaxel) and Xeloda (chemical name: capecitabine).
-
Taxol Weekly Better Than Every Three Weeks for Breast Cancer
Getting Taxol (chemical name: placlitaxel) every week seems to have more benefits than getting it every 3 weeks or getting Taxotere (chemical name: docetaxel) on either schedule.
-
Taxotere Combo Improves Survival
The combination of Taxotere (chemical name: docetaxel) and Cytoxan (chemical name: cyclophosphamide) offers better survival and fewer and less severe side effects than the combination of Adriamycin (chemical name: doxorubicin) and Cytoxan for treating breast cancer.
-
New Chemo Medicines Treat Metastatic Disease
Average survival times for women diagnosed with metastatic breast cancer are increasing because of new medications.
-
Abraxane Better for Metastatic Breast Cancer Than Taxotere
Abraxane more effective than Taxotere for advanced breast cancer.
21–26 of 26 articles
